Both CRSP and NTLA are advancing in vivo gene editing therapies targeting large markets, with financial stability supporting ...

Neuroscientist Gerald Voelbel’s journey from mysterious symptoms to a rare cancer and neurological disorder diagnosis highlights the power of self-advocacy and finding purpose.